Bayer Aspirin Extra Strength Plus Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Bayer Aspirin Extra Strength Plus
K
- K-Lyte (potassium bicarbonate / potassium citrate)
- K-Lyte DS (potassium bicarbonate / potassium citrate)
- K-Pek (bismuth subsalicylate)
- Kabikinase (streptokinase)
- Kadcyla (ado-trastuzumab emtansine)
- kanamycin
- Kantrex (kanamycin)
- Kao-Tin Bismuth Subsalicylate Formula (bismuth subsalicylate)
- Kaopectate (bismuth subsalicylate)
- Kaopectate Anti-Diarrheal Upset Stomach Reliever (bismuth subsalicylate)
- Kaopectate Extra Strength (bismuth subsalicylate)
- Kapectolin (New Formula) (bismuth subsalicylate)
- Kapidex (dexlansoprazole)
- Kapspargo Sprinkle (metoprolol)
- Karbons (charcoal)
- Katerzia (amlodipine)
- Keep Alert (caffeine)
- Keep Going (caffeine)
- Kemeya (drospirenone / ethinyl estradiol)
- Ken-Jec 40 (triamcinolone)
- Kenaject-40 (triamcinolone)
- Kenalog-10 (triamcinolone)
- Kenalog-40 (triamcinolone)
- Kerlone (betaxolol)
- ketamine / ketoprofen / lidocaine topical
- ketoprofen
- ketoprofen / lidocaine topical
- ketorolac
- ketorolac ophthalmic
- ketorolac / phenylephrine ophthalmic
- ketorolac / phenylephrine / proparacaine / tropicamide ophthalmic
- Keveyis (dichlorphenamide)
- Key-Pred (prednisolone)
- Key-Pred SP (prednisolone)
- Khedezla (desvenlafaxine)
- Kinlytic (urokinase)
- Kiprofen (ketoprofen)
- Kisunla (donanemab)
- Kitabis Pak (tobramycin)
- Klofensaid II (diclofenac topical)
- KneeRelief (acetaminophen / caffeine / magnesium salicylate)
- Kola-Pectin DS (bismuth subsalicylate)
- Konvomep (omeprazole / sodium bicarbonate)
- Kori Krill Oil Omega-3 (omega-3 polyunsaturated fatty acids)
- Koselugo (selumetinib)
- Kybella (deoxycholic acid)
- Kyra (drospirenone / ethinyl estradiol)
More about Bayer Aspirin Extra Strength Plus (aspirin)
- Bayer Aspirin Extra Strength Plus consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.